Open access

An Introductory Chapter: Secondary Metabolites

Written By

Durairaj Thirumurugan, Alagappan Cholarajan, Suresh S.S. Raja and Ramasamy Vijayakumar

Published: 05 September 2018

DOI: 10.5772/intechopen.79766

Chapter metrics overview

10,892 Chapter Downloads

View Full Metrics

1. Introduction

The metabolism can be defined as the sum of all the biochemical reactions carried out by an organism. Metabolites are the intermediates and products of metabolism and are usually restricted to small molecules. The term “secondary” introduced by A. Kossel in 1891 implies that while primary metabolites are present in every living cell capable of dividing, the secondary metabolites are present only incidentally and are not of paramount significance for organism’s life. Though secondary metabolites are derived from primary metabolism, they do not make up basic molecular skeleton of the organism. Its absence does not immediately curtail the life of an organism, a feature contrary to primary metabolite, but survival of the organism is impaired to a larger extent. Its presence and synthesis are observed in ecologically disadvantaged species within a phylogenetic group [1].

The difference between primary and secondary metabolite is ambiguous since many of the intermediates in primary metabolism is overlapping with the intermediates of secondary metabolites [2]. Amino acids though considered a product of primary metabolite are definitely secondary metabolite too. Contrary to the observation that sterols are secondary metabolites that are indispensable part of many structural framework of a cell. The mosaic nature of an intermediate indicates common biochemical pathway being shared by primary and secondary metabolism [3]. The secondary metabolites serve as a buffering zone into which excess C and N can be shunted into to form inactive part of primary metabolism. The stored C and N can revert back to primary metabolite by the metabolic disintegration of secondary metabolite when on demand. There is dynamism and a delicate balance between the activities of the primary and secondary metabolism (Figure 1) being influenced by growth, tissue differentiation and development of the cell or body, and also external pressures [4].

Figure 1.

Schematic diagram representing integration of primary and secondary metabolism.

Hence, secondary metabolites or natural products can be defined as a heterogeneous group of natural metabolic products that are not essential for vegetative growth of the producing organisms, but they are considered differentiation compounds conferring adaptive roles, for example, by functioning as defense compounds or signaling molecules in ecological interactions, symbiosis, metal transport, competition, and so on [5]. The multitude of secondary metabolite secretions is harvested by human kind to improve their health (antibiotics, enzyme inhibitors, immunomodulators, antitumor agents, and growth promoters of animals and plants), widen the pyramid of healthy nutrition (pigments and nutraceuticals), enhancing agricultural productivity (pesticides, insecticides, effectors of ecological competition and symbiosis and pheromones), and hence impacting economics our society in a certain positive way. They are a source of antibiotics.


2. Classification of secondary metabolites

Over 2,140,000 secondary metabolites are known and are commonly classified according to their vast diversity in structure, function, and biosynthesis. There are five main classes of secondary metabolites such as terpenoids and steroids, fatty acid-derived substances and polyketides, alkaloids, nonribosomal polypeptides, and enzyme cofactors [6].

2.1. Terpenoids and steroids

They are major group of substances derived biosynthetically from isopentenyl diphosphate. Currently, over 35,000 known terpenoid and steroid compounds are identified. Terpenoids have different variety of unrelated structures, while steroids have a common tetracyclic carbon skeleton and are modified terpenoids that are biosynthesized from the triterpene lanosterol.

2.2. Alkaloids

There are over 12,000 known compounds of alkaloids, and their basic structures consist of basic amine group and are derived biosynthetically from amino acids.

2.3. Fatty acid-derived substances and polyketides

Around 10,000 compounds are identified and are biosynthesized from simple acyl precursors such as propionyl CoA, acetyl CoA, and methylmalonyl CoA.

2.4. Nonribosomal polypeptides

These amino acids derived compounds are biologically synthesized by a multifunctional enzyme complex without direct RNA transcription.

2.5. Enzyme cofactors

Enzyme cofactors are nonprotein, low-molecular enzyme component [6].


3. Functions of secondary metabolites

The major functions of the secondary metabolites including antibiotics are:

  1. competitive weapons against other livings such as animals, plants, insects, and microorganisms

  2. metal transporting agents

  3. agents for symbiotic relation with other organisms

  4. reproductive agent and

  5. differentiation effectors

  6. agents of communication between organisms

The other functions include interference in spore formation (not obligatory) and germination [5]. Predominantly, the secondary metabolites are used for variety of biological activities like antimicrobial and antiparasitic agents, enzyme inhibitors and antitumor agent, immunosuppressive agents, etc. [7].


4. Sources of secondary metabolites

The major sources of secondary metabolites are plants (80% of secondary metabolite), bacteria, fungi, and many marine organisms (sponges, tunicates, corals, and snails) (Table 1) [8].

4.1. Secondary metabolites of plants

Plant secondary metabolites represent highly economically valuable products. These are used as high value chemicals such as drugs, flavors, fragrances, insecticides, dyes, etc. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found to have in vitro antimicrobial properties. Plants have an almost limitless ability to synthesize aromatic substances, most of which are phenols or their oxygen-substituted derivatives [9]. About 25,000 terpenoids are known as secondary compounds and are derived from the five-carbon precursor isopentenyl diphosphate (IPP). In total, around 12,000 known alkaloids are identified, and they possess one or more nitrogen atoms which are biosynthesized from amino acids. The 8000 known phenolic compounds are synthesized either through the shikimic acid pathway or through the malonate/acetate pathway [10].

Many alkaloids are used in medicine, usually in the form of salts. Some examples include vinblastine which has antitumor properties [11]; quinine which has antipyretics and antimalarial properties [12]; and reserpine which can be used to treat high blood pressure. Alkaloids are regarded as reserve materials for protein synthesis, as protective substances discouraging animal or insect attacks, and as plant stimulants or regulators or simply as detoxification products. Alkaloids currently in clinical use include the analgesics morphine and codeine, the anticancer agent vinblastine, the gout suppressant colchicine, the muscle relaxant tubocurarine, the antiarrhythmic ajmalicine, the antibiotic sanguinarine, and the sedative scopolamine.

In vitro studies have shown that natural phenols have antimicrobial [13], antiviral [14], anti-inflammatory [15], and vasodilatory actions [16]. It protects the plant against adverse factors which threaten its survival in an unfavorable environment, such as drought, physical damage or infections. Resistance of plants to UV radiations is due to the phenolic compounds especially the phenylpropanoids present in them [17]. Phenolic compounds act as antioxidants protecting cells from oxidative stress scavenging of free radicals by hydrogen atom donation. The action of phenolic as neuroprotective [18], fungicidal [19], bactericidal [20] compounds and their anti-atherosclerosis [21] effects, and anticancer [22] activity is well documented.

Terpenoids are commercially important fragrance and flavoring agents [23]. Prenol and α-bisabolol are used in fragrance due to fruity odor and sweet floral aroma, respectively. Mono and sesqui terpenes are basis of natural perfumes and also of spices and flavorings in the food industry. The roles of terpenoids as pharmaceutical agents with activities such as antibacterial and antineoplastic are still under investigation. There are examples of diterpenes that exhibited in vitro cytotoxic, antitumor, and antimicrobial activities. Terpenes are vital for life in most organisms exerting metabolic control and mediating inter and intra species interactions, for example, manufacture compounds in response to herbivory or stress factors, and it has also been shown that flowers can emit terpenoids to attract pollinating insects and even attract beneficial mites, which feed on herbivorous insects. Cheng et al. [24] have reported that terpenes may act as chemical messengers influencing the expression of genes involved in plant defensive functions or influence gene expression of neighboring plants. Other secondary metabolite of plant origin and their functions is given in Table 2 [25].

SourceAll known compoundsBioactivesAntibiotics
Natural productsOver one million200,000–250,00025,000–30,000
Plant kingdom600,000–700,000150,000–200,000~25,000
MicrobesOver 50,00022,000–23,000~17,000
Algae, lichens3000–50001500–2000~1000
Higher plants500,000–600,000~100,00010,000–12,000
Animal kingdom300,000–400,00050,000–100,000~5000
ProtozoaSeveral hundreds100–200~50
Marine animals20,000–25,0007000–80003000–4000
Insects/ worms/ etc.8000–10,000800–1000150–200
Vertebrates (mammals, fishes, amphibians, etc.)200,000–250,00050,000–70,000~1000

Table 1.

Approximate number of known natural metabolites.

NA – Data Not Available.

Source: Bérdy [8].

S. No.Secondary metabolitesBiological activity
14.Jandicine N-oxideAntineoplastic
22.DigoxinCardiac tonic
25.ThebaineSource of codeine
27.AlropineMuscle relaxant
29.ShikoninDye, pharmaceutical
30.AnthroquinonesDye, laxative
31.Rosamarinic acidSpice, antioxidant, perfume
37.Gutla perchaEssential oils

Table 2.

Biological activities of some secondary metabolites of plants.

NA – Not Assessed.

Source: Ramawat and Merillon [25].

4.2. Production of secondary metabolites from plants

4.2.1. Conventional

The conventional method of secondary metabolite production relies on extraction of metabolite, not production, from the tissues of plant by different phytochemical procedures like solvent, steam, and supercritical extraction. The recent developments in biotechnological methods like plant tissue culture, enzyme and fermentation technology have facilitated in vitro synthesis and production of plant secondary metabolites. The major processes include:

4.2.2. Immobilization

Cell or biocatalysts are confined within a matrix by entrapment, adsorption or covalent linkage. On addition of suitable substrate and provision on optimum physico chemical parameters, the desired secondary metabolites are synthesized. Immobilization with suitable bioreactor system provides several advantages, such as continuous process operation, but for the development of an immobilized plant cell culture process, natural or artificially induced secretion of the accumulated product into the surrounding medium is necessary.

4.2.3. In vitro tissue, organ, and cell culture

Plant cell and tissue cultures can be established routinely under sterile conditions from explants, such as plant leaves, stems, roots, meristems, etc., both for multiplication and extraction of secondary metabolites. Shoot, root, callus, cell suspension, and hairy root culture are used to synthesize metabolite of interest. Metabolites which are localized in multiple tissues can be synthesized through unorganized callus or suspension cultures. But when the metabolite of interest is restricted to specialized part or glands in host plant, differentiated microplant or organ culture is the method of choice. Saponins from ginseng are produced in its roots, and hence in vitro root culture is preferred for saponin synthesis. Similarly, antidepressant hypericin and hyperforin are localized in foliar glands of Hypericum perforatum, which have not been synthesized from undifferentiated cells [26].

The quantum of secondary metabolite production in cell cultures can be enhanced by treating plant cells with biotic and/or abiotic elicitors. Methyl jasmonate, fungal carbohydrates, and yeast extract are the commonly used elicitors. Methyl jasmonate is an established and effective elicitor used in the production of taxol from Taxus chinensis [27] and ginsenoside from Panax ginseng [28, 29, 30, 31, 32]. The most recently evolved and designed metabolic engineering can be employed to improve the productivity.

The production of metabolites through hairy root system based on inoculation with Agrobacterium rhizogenes has garnered much attention of late. The quality and quantity of secondary metabolite by hairy root systems is same or even better than the synthesis by intact host plant root [33]. In addition, stable genetic make up, instant growth in plant tissue culture media san phytohormones provides additional scope for biochemical studies. Root tips infected with A. rhizogenes are grown on tissue culture media [Murashige and Skoog’s (MS) Gamborg’s B5 or SH media] lacking phytohormones. Srivastava and Srivastava [34] have recently summarized the attempts to adapt bioreactor design to hairy root cultures; stirred tank, airlift, bubble columns, connective flow, turbine blade, rotating drum, as well as different gas phase reactors have all been used successfully. Genetic manipulation in hairy root culture for secondary metabolite production is being tried out. The established roots are screened for higher growth and production of metabolites. Transgenic hairy roots generated though Agrobacterium rhizogenes have not only paved way for plantlet generation but also for synthesis of desired product through transgenic hairy root cultures.

4.3. Secondary metabolites of microorganisms

Microbial secondary metabolites are low molecular mass products with unusual structures. The structurally diverse metabolites show a variety of biological activities like antimicrobial agents, inhibitors of enzymes and antitumors, immune-suppressives and antiparasitic agents [7], plant growth stimulators, herbicides, insecticides, antihelmintics, etc. They are produced during the late growth phase of the microorganisms. The secondary metabolite production is controlled by special regulatory mechanisms in microorganisms, as their production is generally repressed in logarithmic phase and depressed in stationary growth phases. The microbial secondary metabolites have distinctive molecular skeleton which is not found in the chemical libraries and about 40% of the microbial metabolites cannot be chemically synthesized [35].

4.3.1. Features of microbial secondary metabolites

  • The principle and process of natural fermentation product synthesis can be successfully scaled up and employed to maximize its application in the field of medicine, agriculture, food, and environment.

  • The metabolite can serve as a starting material for deriving a product of interest, extended further through chemical or biological transformation.

  • New analog or templates in which secondary metabolite serve as lead compounds will lead discovery and design of new drugs.

4.4. Applications of microbial secondary metabolites

4.4.1. Antibiotics

The discovery of penicillin initiated the researchers for the exploitation of microorganisms for secondary metabolite production, which revolutionized the field of microbiology [5]. With the advent of new screening and isolation techniques, a variety of β-lactam-containing molecules [36] and other types of antibiotics have been identified. About 6000 antibiotics have been described, 4000 from actinobacteria (Table 3). In the prokaryotic group, unicellular bacteria Bacillus (Table 3) and Pseudomonas (Table 3) species are the most recurrent antibiotic producers. Likewise in eukaryotes, fungi are dominant antibiotic producers next to plants (Table 3). In the recent years, myxobacteria and cyanobacteria species have joined these distinguished organisms as productive species.

Name of secondary metabolitesSource of secondary metabolitesBiological activitiesReferences
Secondary metabolites of Actinobacteria
ResistomycinS. corchorusiiHIV-1 protease inhibitorShiono et al. [39]
Himalomycins A and BStreptomyces sp. B6921AntimicrobialMaskey et al. [40]
BonactinStreptomyces sp. BD21–2AntibacterialSchumacher et al. [41]
TrioxacarcinsS. ochraceus and S. bottropensisAntitumor and antimalarialMaskey et al. [42]
Chinikomycins A and BStreptomyces sp.Antitumor and antiviralLi et al. [43]
DaryamidesStreptomyces sp. CNQ-085Cytotoxic polyketidesAsolkar et al. [44]
ResistoflavineS. chibaensisAntibacterialGorajana et al. [45]
Chalcomycin A and terpenesStreptomyces sp. M491AntibacterialWu et al. [46]
Napyradiomycin (C-16 stereoisomers)S. antimycoticusAntibacterialMotohashi et al. [47]
Oxohexaene and CephalaxineStreptomyces sp. RM17; Streptomyces sp. RM42AntibacterialRemya and Vijayakumar [48]
Citreamicin θ A, Citreamicin θ B, and Citreaglycon AS. caelestisAntibacterialLiu et al. [49]
SpiramycinStreptomyces sp. RMS6AntibacterialVijayakumar and Malathi [50]
N-isopentyltridecanamideStreptomyces labedae ECR 77AntibacterialThirumurugan et al. [51]
StaurosporineStreptomyces champavatii KV2AntimicrobialCholarajan and Vijayakumar [52]
Secondary metabolites of Bacillus spp.
CoagulinB. coagulansBactericidal, BacteriolyticLe Marrec et al. [53]
Bacthurucin f4B. thuringenesis sp.Fungicidal sub sp., kurstaki BUPM4Kamoun et al. [54]
CereinB. cereusBactericidal, bacteriolyticBizani et al. [55]
MegacinB. megaterium,Lisboa et al. [56]
Thuricin SB. thuringenesis,Chehimi et al. [57]
Thuricin CD 19B. thuringenesis DPC6431
B. anthracis
,Rea et al. [58]
Halobacillin 5bB. licheniformisHemolytic, cytotoxicKalinovskaya et al. [59]
BacillomycinB. amyloliquefacins FZB42,
B. subtilis
Antifungal hemolyticRamarathnam et al. [60]
BacilysocinB. subtilisFungicidal, antibacterialTamehiro et al. [61]
Bacilysin 1B. subtilis 168, B. pumilus
B. amyloliquefaciens GSB272
Antifungal, antibacterialSteinborn et al. [62]
Secondary metabolites of Pseudomonas spp.
PseudomonineP. stutzeri KCCompetitive inhibition of phytopathogensLewis et al. [63]
Hydrogen cyanideP. pseudoalcaligenes P4AntifungalAyyadurai et al. [64]
Secondary metabolites of Fungi
LovastatinMonascus ruber;
Aspergillus terreus
Enzyme inhibitorDewick [65]
Limonene and guaiolTrichoderma virideAntimicrobialAwad et al. [66]
TuberculariolsTubercularia sp. TF5AnticancerXu et al. [67]
OxalinePenicillium raistrickiAnti-cell proliferationSumarah et al. [68]
Benzomalvin CPenicillium raistrickii, Penicillium sp. SC67AntimalarialStierle et al. [69]
Roquefortine CP. roqueforti; P. crustosumNeurotoxinKim et al. [70]; Xu et al. [67]
PravastatinPenicillium citrinumAnticholesterolemicsGonzalez et al. [71]

Table 3.

Secondary metabolites produced by microorganisms.

The pharmaceutical product, especially anti-infective derivatives comprise 62% antibacterials, 13% sera, immunoglobulins, and vaccines, 12% anti-HIV antivirals, 7% antifungals, and 6% nonHIV antivirals. There are over 160 antibiotics. Streptomyces hygroscopicus with over 200 antibiotics, Streptomyces griseus with 40 antibiotics, and Bacillus subtilis with over 60 compounds are the major contributors to the antibiotic market [7].

4.4.2. Antitumor agents

Natural product and its derivatives account for more than 60% of anticancer formulations. Actinobacteria derived antineoplastic molecules currently in use are actinomycin D, anthracyclines (daunorubicin, doxorubicin, epirubicin, pirarubicin, and valrubicin), bleomycin, mitosanes (mitomycin C), anthracenones (mithramycin, streptozotocin, and pentostatin), enediynes (calicheamicin), taxol, and epothilones [37].

Taxol is the nonactinobacterial molecule derived from plant Taxus brevifolia and endophytic fungi Taxomyces andreanae and Nodulisporium sylviforme. It interferes with microtubule breakdown, an essential event leading to cell division, thereby inhibiting rapidly dividing cancer cells. It is effective against breast and advanced form Kaposi’s sarcoma. It is also found to exhibit antifungal activity against Pythium, Phytophthora, and Aphanomyces.

4.4.3. Pharmacological and nutraceutical agents

One huge success was the discovery of the fungal statins, including compactin, lovastatin, pravastatin, and others which act as cholesterol-lowering agents. Lovastatin is produced by A. terreus. Of great importance in human medicine are the immunosuppressants such as cyclosporin A, sirolimus (rapamycin), tacrolimus, and mycophenolate mofetil. They are used for heart, liver, and kidney transplants and were responsible for the establishment of the organ transplant field. Cyclosporin A is made by the fungus Tolypocladium niveum. Mycophenolate mofetil is a semisynthetic product of the oldest known antibiotic, mycophenolic acid, and is also made by a fungus. Sirolimus and tacrolimus are products of streptomycetes [7]. Metabolites of probiotic bacteria are considered as a remedy for controlling weight gain, preventing obesity, increasing satiety, prolonging satiation, reducing food intake, reducing fat deposition, improving energy metabolism, treating and enhancing insulin sensitivity, and treating obesity. Firmicutes and Bacteroidetes are the dominant beneficial bacteria present in the normal human gastrointestinal tract, and the latter was reported in lower numbers in constipation-predominant irritable bowel syndrome patients [38]. Carotenoids of microbial origin are used as food colorant, fish feeds, nutraceuticals, cosmetics, and antioxidants. Food colorant widely used is carotene derived from Blakeslea trispora, Dunaliella salina and lycopene from B. trispora and Streptomyces chrestomyceticus, subsp. rubescens. Astaxanthin produced from Xanthophyllomyces dendrorhous is an approved fish feed. Astaxanthin, lutein, β-carotene, zeaxanthin, and canthaxanthin are used as nutraceuticals due to their excellent antioxidant property. Docosahexaenoic acid (DHA) used in infant formula as nutritional supplements is derived from microalgae Schizochytrium spp. [7].

4.4.4. Enzymes and enzyme inhibitors

Enzymes produced from microorganism have annual sales of US $ 2.3 billion enzymes that find application in detergents (34%), foods (27%), agriculture and feeds (16%), textiles (10%), and leather, chemicals, and pulp and paper (10%). The protease subtilisin used in detergents has an annual sale of $ 200 million. The other major enzymes include glucose isomerase (100,000 tons) and penicillin amidase (60,000 tons). Nitrilase (30,000 tons) and phytase are amounting for $135 million worth of production. Streptomyces glucose isomerase is used to isomerize D-glucose to D-fructose, to make 15 million tons per year of high fructose corn syrup, valued at $1 billion [7].

The most important enzyme inhibitors are clavulanic acid, synthesized by Streptomyces clavuligerus, the inhibitor of β-lactamases. Some of the common targets for other inhibitors are glucosidases, amylases, lipases, proteases, and xanthine oxidase. Amylase inhibitors prevent absorption of dietary starches into the body, and hence can be used for weight loss [38].

4.4.5. Agricultural and animal health products

Secondary metabolites find wide applications in the field of agriculture and animal health: kasugamycin and polyoxins are used as biopesticides; Bacillus thuringiensis crystals, nikkomycin, and spinosyns are used as bioinsecticides; bioherbicides (bialaphos) find application as bioherbicides; ivermectin and doramectin as antihelmintics and endectocides against worms, lice, ticks, and mites; ruminant growth promoters in the form of coccidiostats; plant hormones like gibberellins as growth regulators are the most common application [7].

4.5. Production of secondary metabolites from microorganisms

Secondary metabolites branch out from the pathways of primary metabolism. Commercially, important secondary and primary metabolic pathways are given in Table 4.

S. No.Intermediates from primary metabolic pathwaySecondary metabolites derived
1.Shikimic acidErgot alkaloids, antibiotics: candicidin and chloramphenicol
2.Amino acidsAntibiotics: penicillin, cephalosporins and cephamycins, and gramicidin, immunosuppressive cyclosporine
3.Acetyl-CoA and other Kreb’s cycle intermediatesAntibiotics: erythromycin, antiparasitic avermectin antitumor doxorubicin, taxol
4.SugarsAntibiotics: streptomycin and kanamycin.

Table 4.

Intermediate from primary metabolism and their secondary metabolite derivatives.

4.5.1. Liquid fermentation

Batch or fed-batch culture in submerged fermentation is employed for production of secondary metabolites. Inoculum is developed after careful strain improvement of producing organism. Initially, shake flasks culture is employed, and the culture which are in active growth phase are transferred to a small fermenter and later into a larger fermenter with production medium. Several parameters, like medium composition, pH, temperature, and agitation and aeration rate, are controlled. An inducer such as methionine is added to cephalosporin fermentations, phosphate is restricted in chlortetracycline fermentation, and glucose is avoided in penicillin or erythromycin fermentation.

4.5.2. Solid-state fermentation

Solid-state fermentation, defined as a microbial culture that develops on the surface and at the interior of a solid matrix and in the absence of free water, holds an important potential for the production of secondary metabolites. Two types of SSF can be distinguished, depending on the nature of solid phase used [7]: (a) solid culture of one support-substrate phase solid phase and (b) solid culture of two substrate-support phase solid phase. The advantages of solid-state fermentation in relation with submerged fermentation include: energy requirements of the process are relatively low, since oxygen is transferred directly to the microorganism. Secondary metabolites are often produced in much higher yields, often in shorter times, and often sterile conditions are not required [7].

It is important here to note our own experience of deriving actinobacterial secondary metabolite. Actinobacteria from terrestrial and marine habitats were screened for their antimicrobial activity. The bioactive metabolites were extracted and purified by thin layer and column chromatography, and the structure of the metabolite was elucidated by UV-spectrometry, FT-IR, mass spectrum analysis, and NMR. The derived metabolites staurosporine, octa-valinomycin, methyl-4,8-dimethylundecanate, and N-isopentyltridecanamide are known for their biological activity (Figure 2).

Figure 2.

Chemical structures of actinobacterial secondary metabolites. (a) Staurosporine, (b) octa-valinomycin, (c) methyl-4,8-dimethylundecanate, and (d) N-isopentyltridecanamide from actinobacteria. Source: Cholarajan and Vijayakumar [52]; Cholarajan [72]; Thirumurugan et al. [73].


5. Conclusion

This review emphasizes the importance of secondary metabolites from various sources like plants, microorganisms including bacteria, actinobacteria, and fungi and its classification, production and applications in various fields. Since there is a constant and crucial requirement for new pharmaceutical agents to fight cancers, cardiac disorders, pests, cytotoxic, mosquitoes, infectious diseases, and autoimmune disorders of both animals and plants as climate changes provide conditions favorable to repeated outbreaks of these events. The battle against any disease is a vibrant symmetry between advances in chemotherapy and natural selection on infectious or invasive agents. If the scientific community is to put constant importance in this never ending effort, then new sources of bioactive secondary metabolites with novel activities must be found. Secondary metabolites are one of their essential means of growth and defense, and these metabolites are readily available for discovery. Secondary metabolites with noteworthy biological activity are considered as an alternative to most of the synthetic drugs and other commercially valuable compounds.


  1. 1. Tiwari R, Rana CS. Plant secondary metabolites: A review. International Journal Of Engineering Research and General Science. 2015;3(5):661-670
  2. 2. Verpoorte R, van der Heijden R, Memelink J. Engineering the plant cell factory for secondary metabolite production. Transgenic Research. 2000;9:323-343
  3. 3. Yeoman MM, Yeoman CL. Tansley review no. 90, manipulating secondary metabolism in cultured plant cells. The New Phytologist. 1996;134:553-569
  4. 4. Collin HA. Secondary product formation in plant tissue cultures. Plant Growth Regulation. 2001;34:119-134
  5. 5. Demain AL, Fang A. The natural functions of secondary metabolites. Advances in Biochemical Engineering/Biotechnology. 2000;69:1-39
  6. 6. McMurry JE. Organic chemistry with biological applications. In: Secondary Metabolites: An Introduction to Natural Products Chemistry. Stamford, USA: Cengage Learning Ltd; 2015. pp. 1016-1046
  7. 7. Demain AL. Pharmaceutically active secondary metabolites of microorganisms. Applied Microbiology and Biotechnology. 1999;52(4):455-463
  8. 8. Bérdy J. Bioactive microbial metabolites. The Journal of Antibiotics. 2005;58(1):1-26
  9. 9. Elvin-Lewis M, Lewis WH. New concepts and medical and dental ethnobotany. In: Schultes R, Von Reis S, editors. Ethnobotany Evolution of a Discipline. Portland: Discords Press; 1995. pp. 303-310
  10. 10. Rodney C, Toni M, Kutchan N, Lewis G. Biochemistry and molecular biology of plants. In: Buchanan B, Gruissem W, Jones R, editors. Natural Products. Rockville, MD., USA: Wiley; 2000. pp. 1253-1348
  11. 11. Jordan MA, Leslie W. Microtubules as a target for antic cancer drugs. Nature Reviews Cancer. 2004;4(4):253-265
  12. 12. Reyburn H, Mtove G, Hendriksen I, von Seidlein L. Oral qui-nine for the treatment of uncomplicated malaria. British Medical Journal (Clinical Research Edition). 2009;339:b2066. DOI: 10.1136/bmj.b2066
  13. 13. Rauha JP, Remes S, Heinonen M, Hopia A, Kkahkonen M, Kuyala T, Pihlaya K, Vuorela H, Vuorela P. Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds. International Journal of Food Microbiology. 2000;56:3-12
  14. 14. Perez DP, Lim W, Seiler JP, Yi G, Peiris M, Shortridge KF, Webster RG. Role of quail in the interspecies transmission of h9 influenza A viruses: Molecular changes on HA that correspond to adaptation from ducks to chickens. Journal of Virology. 2003;77(5):3148-3156
  15. 15. Santos ARS, De Campos ROP, Miguel OG, Filho VC, Siani AC, Yunes RA, Calixto JB. Antinociceptive properties of extracts of new species of plants of the genus Phyllanthus (Euphorbiaceae). Journal of Ethnopharmacology. 2000;72:229-238
  16. 16. Padilla A, Hogan R, Kaiser RB. The toxic triangle: Destructive leaders, susceptible followers, and conducive environments. The Leadership Quarterly. 2007;18:176-194
  17. 17. Dietrich H, Rechner A, Patz CD. Bioactive compounds in fruit and juice. Fruit Process. 2004;1:50-55
  18. 18. Nichenametla SN, Taruscio TG, Barney DL, Exon JH. A review of the effects and mechanism of polyphenolics in cancer. Critical Reviews in Food Science and Nutrition. 2006;46:161-183
  19. 19. Prats E, Galindo JC, Bazzalo ME, León A, Macías FA, Rubiales D, Jorrín JV. Antifungal activity of a new phenolic compound from Capitulum of a head rot-resistant sunflower genotype. Journal of Chemical Ecology. 2007;33:2245-2253
  20. 20. Okunade A, Hufford C, Clark A, Lentz D. Antimicrobial properties of the constituents of Piper aduncum. Phytotherapy Research. 1997;11:142-144
  21. 21. Tsuda H, Ishitani Y, Takemura Y, Suzuki Y, Kato T. 6-acetyl-8-hydroxy-2, 2-dimethylchromene, an antioxidant in sunflower seeds; its isolation and synthesis and antioxidant activity of its derivatives. Heterocycles. 1997;44:139-142
  22. 22. Olsson ME, Gustavsson KE, Andersson S, Nilsson A, Duan RD. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. Journal of Agricultural and Food Chemistry. 2004;52:7264-7271
  23. 23. Ohloff G. Riechstoffe und Geruchssinn. Die molekulare Welt der Düfte, Springer, Berlin, 1990, ISBN 3-540-52560-2. English translation: Scent and Fragrances: The Fascination of Odors and Their Chemical Perspectives. New York: Springer; 1994
  24. 24. Cheng A, Lou Y, Mao Y, Lu S, Wang L, Chen X. Plant terpenoids: Biosythesis and ecological functions. Journal of Integrative Plant Biology. 2007;49:179-186
  25. 25. Ramawat KG, Merillon JM. Biotechnology Secondary Metabolites Plants and Microbes. 2nd ed. London: Taylor and Francis Group, CRC Press; 2007
  26. 26. Smith MAL, Kobayashi H, Gawienowski M, Briskin DP. An in vitro approach to investigate chemical synthesis by three herbal plants. Plant Cell, Tissue and Organ Culture. 2002;70:105-111
  27. 27. Wu J, Lin L. Enhancement of taxol production and release in Taxus chinensis cell cultures by ultrasound, methyl jasmonate and in situ solvent extraction. Applied Microbiology and Biotechnology. 2003;62(2-3):151-155
  28. 28. Yu KW, Gao WY, Son SH, Paek KY. Improvement of ginsenoside production by jasmonic acid and some other elicitors in hairy root culture of ginseng (Panax ginseng C.A. Meyer). In Vitro Cellular & Developmental Biology. 2000;36(5):424-428
  29. 29. Yu GY, Sinclair JB, Hartman GL, Bertagnolli BL. Production of iturin a by Bacillus amyloliquefaciens suppressing Rhizoctonia solani. Soil Biology and Biochemistry. 2002;34:955-963
  30. 30. Kim OT, Kim MY, Hong MH, Ahn JC, Huang B. Stimulation of asiticoside accumulation in the whole plant cultures of Centella asiatica (L.) urban by elicitors. Plant Cell Reports. 2004;23:339-344
  31. 31. Thanh NT, Murthy HN, Yu KW, Hahn EJ, Paek KY. Methyl jasmonate elicitation enhanced synthesis of ginsenoside by cell suspension cultures of Panax ginseng in 5-l balloon type bubble bioreactors. Applied Microbiology and Biotechnology. 2005;67(2):197-201
  32. 32. Palazon J, Pinol MT, Cusido RM, Morales C, Bonfill M. Application of transformed root technology to the production of bioactive metabolites. Recent Res Dev Pl. Phys. 1997;1:125-143
  33. 33. Sevon N, Oksman-Caldentey KM. Agrobacterium rhizogenesmediates transformation: Root cultures as a source of alkaloids. Planta Medica. 2002;68:859-868
  34. 34. Shrivasava N, Patel T, Srivastava A. Biosynthetic potential of in vitro grown callus cells of Cassia senna L. var. senna. Current Science. 2006;90:1472-1473
  35. 35. Feher M, Schmidt JM. Property distribution: Difference between drugs, natural products and molecules from combinatorial chemistry. Journal of Chemical Information and Computer Sciences. 2003;43(1):218-227
  36. 36. Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Annals of Internal Medicine. 1992;116:285-292
  37. 37. Renner MK, Shen YC, Cheng XC, Jensen PR, Frankmoelle W, Kauffman CA, Fenical W, Lobkovsky E, Cladry J. Cyclomarins A-C, new anti-inflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). Journal of the American Chemical Society. 1999;121:11273-11276
  38. 38. Moore BS, Trischman JA, Seng D, Kho D, Jensen PR, Fenical W. Salinamides, anti-inflammatory depsipeptides from a marine Streptomycete. The Journal of Organic Chemistry. 1999;64(4):1145-1150
  39. 39. Shiono Y, Shiono N, Seo S, Oka S, Yamazaki Y. Effects of polyphenolic anthrone derivatives resistomycin and hypericin on apoptois in human megakaryoblastic leukemia CMK-7cell2. Zeitschrift für Naturforschung. 2002;57(9-10):923-929
  40. 40. Maskey RP, Helmke E, Laatsch H. Himalomycin A and B: Isolation and structure elucidation of a new fridamycin type antibiotics from a marine Streptomyces isolate. The Journal of Antibiotics. 2003;56(11):942-949
  41. 41. Schumacher RW, Talmage SC, Miller SA, Sarris KE, Davidson BS, Goldberg A. Isolation and structure determination of an antimicrobial ester from a marine-derived bacterium. Journal of Natural Products. 2003;66:1291-1293
  42. 42. Maskey RP, Helmke E, Kayser O, Fiebig HH, Maier A, Busche A, Laatsch H. Anticancer and antibacterial trioxacarcins with high anti-malarial activity from a marine Streptomycete and their absolute stereochemistry. The Journal of Antibiotics. 2004;57(12):771-779
  43. 43. Li F, Maskey RP, Qin S, Sattler I, Fiebig HH, Maier A, Zeeck A, Laatsch H. Chinikomycins A and B isolation, structure elucidation and biological activity of novel antibiotics from a marine Streptomyces sp. isolate MO45. Journal of Natural Products. 2005;68(1):349-353
  44. 44. Asolkar RN, Jensen PR, Kauffman CA, Fenical W. Daryamides A-C, weakly cytotoxic polyketides from a marine-derived actinomycete of the genus Streptomyces strain CNQ-085. Journal of Natural Products. 2006;69(12):1756-1759
  45. 45. Gorajana AMV, Vinjamuri S, Kurada BV, Peela S, Jangam P, Poluri E, Zeeck A. Resistoflavine cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN(1)/7. Microbiological Research. 2007;162(4):322-327
  46. 46. Wu SJ, Fotso S, Li F. Amorphane sesquiterpenes from a marine Streptomyces sp. Journal of Natural Products. 2007;70(2):304-306
  47. 47. Motohashi K, Sue M, Furihata K, Ito S, Seto H. Terpenoids produced by actinomycetes: Napyradiomycins from Streptomyces antimycoticus NT17. Journal of Natural Products. 2008;71(4):595-601
  48. 48. Remya M, Vijayakumar R. Isolation and characterization of marine antagonistic actinomycetes from west coast of India. Facta Universitatis, Series: Medicine and Biology. 2008;15(1):13-19
  49. 49. Liu L, Xu Y, Han Z, Li Y, Lu L, Lai P, Zhong J, Guo X, Zhang X, Qian P. Four new antibacterial xanthones from the marine derived actinomycetes Streptomyces caelestis. Marine Drugs. 2012;10(11):2571-2583
  50. 50. Vijayakumar R, Malathi R. Isolation, characterization and antibacterial activity of actinobacteria from dye polluted soils of Tirupur. Facta Universitatis, Series: Medicine and Biology. 2014;16(1):43-48
  51. 51. Thirumurugan D, Vijayakumar R. Characterization and structure elucidation of antibacterial compound of Streptomyces sp. ECR77 isolated from East Coast of India. Current Microbiology. 2015;70:745-755
  52. 52. Cholarajan A, Vijayakumar R. Screening of antibiotic (staurosporine) producing actinobacteria (Streptomyces sp.) from terrestrial environment soil of Thanjavur district, Tamilnadu, India. European Journal of Biomedical and Pharmaceutical Sciences. 2016;3(3):480-493
  53. 53. Le Marrec C, Hyronimus B, Bressollier P, Verneuil B, Urdaci MC. Biochemical and genetic characterization of coagulin, a new antilisterial bacteriocin in the pediocin family of bacteriocins, produced by Bacillus coagulans I4. Applied and Environmental Microbiology. 2000;66:5213-5220
  54. 54. Kamoun F, Mejdoub H, Aouissaoui H, Reinbolt J, Hammami A, Jaoua S. Purification, amino acid sequence and characterization of bacthuricin F4, a new bacteriocin produced by Bacillus thuringiensis. Journal of Applied Microbiology. 2005;98:881-888
  55. 55. Bizani D, Dominguez APM, Brandelli A. Purification and partial chemical characterization of the antimicrobial peptide cerein 8A. Letters in Applied Microbiology. 2005;41:269-273
  56. 56. Lisboa MP, Bonatto D, Bizani D, Henriques JAP, Brandelli A. Characterization of a bacteriocin-like substance produced by Bacillus amyloliquefaciens isolated from the Brazilian Atlantic forest. International Microbiology. 2006;9:111-118
  57. 57. Chehimi S, Delalande F, Sable S, Hajlaoui MR, Van Dorsselaer A, Limam F, Pons AM. Purification and partial amino acid sequence of thuricin S, a new anti- Listeria bacteriocin from Bacillus thuringiensis. Canadian Journal of Microbiology. 2007;53:284-290
  58. 58. Rea MC, Sit CS, Claytona E, O Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C. Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:9352-9357
  59. 59. Kalinovskaya N, Kuznetsova TA, Ivanova EP, Romanenko LA, Voinov VG, Huth F, Laatsch H. Characterization of surfactin-like cyclic depsipeptides synthesized by Bacillus pumilus from ascidian Halocynthia aurantium. Marine Biotechnology. 2002;4:179-189
  60. 60. Ramarathnam R, Bo S, Chem Y, Fernando WGD, Xuewen G, de Kievit T. Molecular and biochemical detection of fengycin and bacillomycin D producing Bacillus spp., antagonistic to fungal pathogens of canola and wheat. Canadian Journal of Microbiology. 2007;53:901-911
  61. 61. Tamehiro N, Okamoto-Hosoya Y, Okamoto S, Ubukata M, Hamada M, Naganawa H, Ochi K. Bacilysocin, a novel phospholipid antibiotic produced by Bacillus subtilis 168. Antimicrobial Agents and Chemotherapy. 2002;46:315-320
  62. 62. Steinborn G, Hajirezaei MR, Hofemeister J. Bac genes for recombinant bacilysin and anticapsin production in Bacillus host strains. Archives of Microbiology. 2005;183:71-79
  63. 63. Lewis TA, Cortese MS, Sebat JL, Green TL, Lee CH, Crawford RL. A Pseudomonas stutzeri gene cluster encoding biosynthesis of the CCl4-dechlorination agent pyridine-2, 6-bis (thiocarboxylic acid). Environmental Microbiology. 2000;2:407-416
  64. 64. Ayyadurai N, Ravindra Naik P, Sakthivel N. Functional characterization of antagonistic fluorescent pseudomonads associated with rhizospheric soil of rice (Oryza sativa L.). Journal of Microbiology and Biotechnology. 2007;17:919-927
  65. 65. Dewick PM. Medicinal Natural Products: A Biosynthetic Approach. 3rd ed. Chichester, UK: John Wiley and Sons, Ltd; 2009
  66. 66. Awad NE, Kassem HA, Hamed MA, El-Feky AM, Elnaggar MAA, Mahmoud K, Ali MA. Isolation and characterization of the bioactive metabolites from the soil derived fungus Trichoderma viride. Mycology. 2018;9(1):70-80
  67. 67. Xu R, Wang MZ, Lu CH, Zheng ZH, Shen YM. Tuberculariols A–C, new sesquiterpenes from the mutant strain M-741 of Tubercularia sp. TF 5. Helvetica Chimica Acta. 2009;92:1514-1519
  68. 68. Sumarah MW, Kesting JR, Sorensen D, Miller JD. Antifungal metabolites from fungal endophytes of Pinus strobus. Phytochemistry. 2011;72:1833-1837
  69. 69. Stierle AA, Stierle DB. Bioactive compounds from four endophytic Penicillium sp. isolated from the Northwest Pacific yew tree. In: Atta-Ur-Rahman, editor. Bioactive Natural Products. Vol. 24. Amsterdam: Elsevier Science Publishers; 2000. pp. 933-978
  70. 70. Kim S, Shin DS, Lee T, Oh KB. Periconicins, two new fusicoccane diterpenes produced by an endophytic fungus Periconia sp. with antibacterial activity. Journal of Natural Products. 2004;67:448-450
  71. 71. Gonzalez JB, Fernandez FJ, Tomasini A. Microbial secondary metabolites production and strain improvement. Indian Journal of Biotechnology. 2003;2:322-333
  72. 72. Cholarajan A. Diversity, characterization and antimicrobial compounds from actinobacteria in terrestrial soil of Thanjavur District, Tamilnadu, India [Ph.D. thesis]. Tiruchirapalli, India: Bharathidasan University; 2014. p. 71
  73. 73. Thirumurugan D, Vijayakumar R, Vadivalagan C, Alam Khan MK, Karthika P. Isolation, structure elucidation and antibacterial activity of methyl-4,8-dimethylundecanate from the marine actionbacterium Streptomyces albogriseolus ECR64. Microbial Pathogenesis. 2018;121:166-172

Written By

Durairaj Thirumurugan, Alagappan Cholarajan, Suresh S.S. Raja and Ramasamy Vijayakumar

Published: 05 September 2018